checkAd

     308  0 Kommentare Multiple Presentations to Showcase Glaukos Products at 2019 European Society of Cataract and Refractive Surgeons Congress

    Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its products will be included in various presentations at the 37th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), which begins Saturday, September 14, 2019 at the Paris Expo, Porte de Versailles in Paris, France.

    Glaukos will sponsor a symposium entitled “Introducing iStent inject W: The Trabecular Micro-Bypass Stent for Cataract Surgeons” on September 14, at 6 pm (CEST) in Pavilion 7, Room South 3. Symposium faculty includes Thomas Samuelson, MD, a U.S. surgeon who will serve as moderator; Christophe Baudouin, MD, PhD from France; Kjell Gunnar Gundersen, MD from Norway; and Fritz Hengerer, MD from Germany. Glaukos will be exhibiting on the showroom floor throughout ESCRS at booth #B105 and its products will be included in various physician presentations, including (all times CEST):

    Sunday, September 15

    Presented Poster Sessions – Glaucoma I and Glaucoma II
    Poster Village, Pod 3

    • 10:20 am – Sustained intraocular pressure (IOP) and medication reduction after Micro-Invasive Glaucoma Surgery (MIGS) with second-generation trabecular bypass stents in open-angle glaucoma (OAG): 48-month outcomes
      Presenting Author: F. Aptel
    • 10:35 am – A budget-impact analysis of the iStent inject trabecular micro-bypass system vs trabeculectomy for the treatment of glaucoma from a German payer perspective
      Presenting Authors: H. Falvey, A. Buchholz, P. Buchholz, S. Bluemle, C. Steeds
    • 10:45 am – A study on outcomes of second-generation iStent inject micro-bypass with cataract surgery
      Presenting Authors: K. Suleiman, R. Bafiq, T. Ressiniotis
    • 3:00 pm – Clinical effectiveness and safety of phaco combined with iStent inject G1 and iStent inject G2 in glaucoma service
      Presenting Authors: S. Pipis, G. Panos, A. Vergados
    • 3:55 pm – Safety and efficacy of iStent inject trabecular micro-bypass stents during phacoemulsification for OAG associated with cataract
      Presenting Authors: D. Cela, E. Brasnu, P. Hamard, C. Baudouin, A. Labbe
    • 4:00 pm – Single-surgeon experience with iStent trabecular micro-bypass implanted in conjunction with cataract surgery: long-term outcomes
      Author: M. Gallardo; Presenter: P. Singh

    Free Paper Session – Micro-Invasive Glaucoma Surgery
    Free Paper Forum, Podium 4

    • 2:00 pm – IOP-lowering effect with the iStent inject in primary OAG eyes with or without history of previous ocular surgery
    Seite 1 von 6



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Multiple Presentations to Showcase Glaukos Products at 2019 European Society of Cataract and Refractive Surgeons Congress Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its products will be included in …